Relapsed acute lymphoblastic leukemia (ALL) has remained challenging to treat in children,
with survival rates lagging well behind those observed at initial diagnosis. Although there …

Acute lymphoblastic leukaemia (ALL) is a relevant form of childhood neoplasm, as it
accounts for over 80% of all leukaemia cases. T-cell ALL constitutes a genetically …

Acute lymphoblastic leukemia (ALL) with fusions of ABL-class tyrosine kinase genes other
than BCR:: ABL1 occurs in∼ 3% of children with ALL. The tyrosine kinase genes involved in …

Platelet-derived growth factor receptor B (PDGFRB) gene rearrangements define a unique
subgroup of myeloid and lymphoid neoplasms frequently associated with eosinophilia and …

Background Angiogenic factor with G-patch and FHA domain 1 (AGGF1), as a newly
identified human angiogenic factor, is overexpressed in some types of malignant tumors and …

T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) are
rare aggressive hematologic malignancies. Current treatment consists of intensive …

Recently, we have presented a scheme, termed “NKL-code”, which describes physiological
expression patterns of NKL homeobox genes in early hematopoiesis and in lymphopoiesis …

Angiogenic factor with G-patch and FHA domains 1 (AGGF1) exhibits a dynamic distribution
from the nucleus to the cytoplasm in endothelial cells during angiogenesis, but the biological …

Background PDGFRB fusions in acute lymphoblastic leukemia (ALL) is rare. The authors
identified 28 pediatric PDGFRB‐positive ALL. They analyzed the features, outcomes, and …

目的: 探讨AGGF1 (angiogenic factor with G and FHA domains 1) 在乳腺癌中的表达及其与
乳腺癌患者预后的意义. 方法: 利用免疫组织化学方法检测110 例乳腺癌组织及配对癌旁正常 …